1998
DOI: 10.1001/jama.279.19.1571
|View full text |Cite
|
Sign up to set email alerts
|

Time to Act on Drug Safety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
35
0
1

Year Published

1999
1999
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 96 publications
(37 citation statements)
references
References 14 publications
1
35
0
1
Order By: Relevance
“…For example, liver reactions associated with some antibiotics were first identified worldwide by Australian reports. It is estimated that 50 per cent of marketed medicines have serious adverse drug reactions first detected after marketing (Moore et al 1998).…”
Section: Adverse Drug Reactionsmentioning
confidence: 99%
“…For example, liver reactions associated with some antibiotics were first identified worldwide by Australian reports. It is estimated that 50 per cent of marketed medicines have serious adverse drug reactions first detected after marketing (Moore et al 1998).…”
Section: Adverse Drug Reactionsmentioning
confidence: 99%
“…suicide in depression, or heart disease in diabetes). In the event, clinically important post-marketing safety concerns have emerged for 50% of approved drugs [15]. This, somewhat unfairly, is seen as a failure of regulation rather than a success for pharmacovigilance.…”
Section: Catch-22mentioning
confidence: 99%
“…But in the opinion of some, FDA lacks the mandate, the money, and the staff to provide effective and efficient surveillance of over 5000 drugs already in the marketplace. 24 Although reporting of adverse effects by manufacturers is mandatory, late or nonreporting of cases by drug companies are major problems. Some companies have been prosecuted for failure to report, and the FDA has issued several warning letters as a result of late reporting.…”
Section: Postmarketing Surveillance Of New Productsmentioning
confidence: 99%